New China Coronavirus vaccine to be tested on humans!
China has agreed to test humans for the corona virus vaccine, which has been cultivated in insect cells, the local government in southwest Chengdu announced.
China is in the midst of a global competition to develop affordable policies to call for the end of the COVID-19 epidemic.
The use of insect cells to enhance the protein growth for the New China Coronavirus vaccine – the first of its kind in China – could accelerate mass production, the Chengdu government said in a Coronavirus vaccine latest update.
Developed by Sichuan University’s West China Hospital in Chengdu, the vaccine has been approved by the National Medical Product Administration for human clinical trials.
In the study of monkeys, the vaccine had indicated the prevention of SARS-CoV-2 infection, without obvious side effects, the Coronavirus vaccine news stated.
Chinese scientists have already entered at least eight corona virus vaccines at different stages of clinical trials.
Foreign players from the United States, including Bioendech of Germany and Innovio Pharma, have teamed up with local companies to test their vaccine in China.
China National Pharmaceutical Group (Sinopharm), has entered the Phase 3 trial in the United Arab Emirates which already has 15,000 volunteers. It also received approval to be tested in Bahrain in a phase 3 study designed to accommodate nearly 6,000 participants.
Authorities in Peru and Morocco have approved a Class 3 clinical trial of a possible Covid-19 vaccine which has been developed by China National Biotec Group (CNBG).
The Phase 3 trial, which usually involves a few thousand participants, allows researchers to collect data on the use of final authorization of the vaccines.
Prior to the recent human trial approval, Chinese researchers and companies have had eight vaccines at various stages of human testing, in China and internationally.
Question: Is it legal how the New China Coronavirus vaccine will be tested on humans?